POWERFUL NEXT GENERATION INTRACELLULARLY DELIVERY PLATFORM TO ACCELERATE MACROMOLECULE THERAPEUTIC DISCOVERY
Taking full advantage of the endocytic pathway, Tana-porter™ is an extremely safe and efficient endosomal translocation & release platform. Tana-Porter™ achieved:
>95% cell viability post exposure,
>90% payload release, and
rivals viral vector AAV in transfection.
Tana-Porter™ can enhance the efficacy of currently available intracellularly active drugs i.e. chemotherapeutics thereby reducing dosage requirements and thus decrease toxicity and side effects profile.
Tana-porter™ makes it possible for biologics and macromolecules such as DNA, various RNA, and proteins to reach their intracellular target and realize their therapeutic potentials.